MRSA Testing Market Size 2024-2028

The Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market size is estimated to grow by USD 880.6 million between 2023 and 2028 accelerating at a CAGR of 13.64%. The market's expansion relies on various elements, such as the escalating prevalence of staphylococcal infections, the implementation of novel MRSA diagnostic tests, and the enhanced integration of automation and systems in the healthcare sector. While the market demonstrates growth, it also faces obstacles like a scarcity of skilled practitioners. However, certain market trends like the increasing utilization of MRSA quick tests employing lab-on-chip technology and the emergence of PCR-free electrochemical point-of-care (POC) testing for swift clinical detection of MRSA will stimulate market growth.

What will be the size of the MRSA Testing Market Report During the Forecast Period?

To learn more about this report, Download MRSA Testing Request Market Research Report Sample PDF

Market Dynamics

The market is a significant sector in the life sciences industry, focusing on detecting and identifying MRSA infections. Various testing methods are employed, including culture-based techniques and molecular techniques such as PCR (Polymerase Chain Reaction) and nucleic acid amplification tests (NAATs). Key components of MRSA testing include inspection equipment, such as microbiology media and automation systems, and equipment for designing, manufacturing, and supply chain services. Passive components, like culture plates and swabs, and active components, like automated systems and robotics, are crucial for efficient and accurate testing. Artificial Intelligence (AI) and Machine Learning (ML) are increasingly being integrated into MRSA testing systems to enhance automation and improve diagnostic accuracy. The healthcare sector is a major end-user, with consumer electronics, IT & telecommunication, industrial, aerospace & defense, and other industries also utilizing MRSA testing. Key companies in the MRSA testing market include 3M, bioMérieux, Becton, Dickinson and Company, and Abbott Laboratories, among others.

The global MRSA testing market is witnessing significant growth due to the increasing incidence of Staphylococcus aureus infections caused by methicillin-resistant strains. These infections, often contracted in hospitals, can lead to surgical site infections, pneumonia, and bloodstream infections. Immunodiagnostic and molecular diagnostic tests are increasingly being used for the detection of MRSA due to their high accuracy and speed. These tests help in identifying MRSA strains resistant to beta-lactam antibiotics, a common drug class used to treat Staphylococcus aureus infections. Next-generation antibiotics such as lipopeptides (daptomycin), oxazolidinones (linezolid), and tetracyclines are being explored as alternatives to treat MRSA infections. Hospital pharmacies, retail pharmacies, and online pharmacies are key distributors of these antibiotics. Hospital-acquired MRSA infections are a major concern, driving the demand for MRSA testing. The market is expected to grow at a steady pace due to the increasing awareness of the importance of early detection and treatment of MRSA infections. In conclusion, the MRSA testing market is a growing industry driven by the rising incidence of MRSA infections, the need for accurate and rapid diagnostic tests, and the development of next-generation antibiotics. The market includes various stakeholders such as diagnostic laboratories, pharmacies, and biotechnology companies.

Key Market Driver

The increasing incidence of staphylococcal infections is a key factor driving the growth of the global market. The emergence of antibiotic-resistant staphylococcal strains, such as MRSA and VRSA, has led to an increased incidence of staphylococcal infections. Most staphylococcal infections are known to develop in hospitals and other healthcare settings, such as dialysis centers and nursing homes. Prolonged hospitalization and increased exposure to open body surfaces due to the use of invasive clinical procedures have led to a rise in staphylococcal infections in healthcare settings.

The rising incidence of staphylococcal infections, particularly skin and soft tissue infections, poses a significant challenge in healthcare. This trend is further compounded by the increasing antimicrobial drug resistance, leading to treatment failures in outpatient settings. Consequently, the market for antimicrobial agents and diagnostic tools is experiencing robust growth. Syphilis, another sexually transmitted infection, also contributes to the demand for diagnostic testing. Syphilis testing is crucial for early detection and treatment, as the disease can lead to severe health complications if left untreated. The market for syphilis diagnostic tests is anticipated to expand due to the rising prevalence of sexually transmitted infections and the need for accurate and rapid diagnostic tools. Thus, the growing burden of staphylococcal infections and the ongoing demand for syphilis testing are key drivers fueling market growth in the market forecast period.

Significant Market Trends

The rise in the use of MRSA quick tests using lab-on-chip technology in hospital settings is the primary trend in the global market growth. Those admitted into hospitals are tested for MRSA bacteria, whereas conventional laboratory sample testing takes more time to provide results. The lab-on-chip (LoC) is a small microfluidic component through which MRSA can be detected in one hour. This device identifies the presence of the MRSA virus in nasal swabs at the time of admission into hospitals. The sample is directly inserted into the LoC and placed in the analysis system. The main advantage of the LoC testing method is that the isolation and treatment of the patient can be initiated immediately if tested positive.

Moreover, LoC has multiple functions like storage, transport, mixing, separation, and detection of biological substances. The compact size and affordability have ensured considerable market growth. The recent device being tested for application in MRSA testing is Bactoquick from Germany-based DNE. This is a potential trend for the market in focus, which may drive its growth during the market research and growth period.

Major Market Challenge

A shortage of trained professionals is a major challenge to the growth of the global market. Processes involved in MRSA testing require the accurate interpretation of results, and researchers must be aware of what analysis to carry out and how to correlate it with the overall objective of the experiment. Hence, for successful research experiments, the researcher needs to have proper knowledge of the science involved. Therefore, the process of the detection of MRSA must be performed by highly skilled personnel.

The adoption of critical experiments is relatively new in the developing countries of APAC, Africa, and South America. Most laboratory technicians have not trained adequately on the latest technology in laboratory equipment and its benefits. Moreover, there is a shortage of trained professionals who can handle technologically advanced diagnostic devices. The lack of expertise increases the probability of a wrong diagnosis. Hence, the shortage of trained professionals will affect the market growth analysis during the forecast period.

Key Market Customer Landscape

The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global MRSA Testing Market Customer Landscape

Who are the Major MRSA Testing Market companies?

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

Arlingtonscientific- The company offers MRSA testing such as Color Staph. Also, under this segment, the company focuses on the development, manufacturing, and sales of in-vitro diagnostics, diagnostic analyzers for syphilis screening, face shields, medical donor lounges for Apheresis and Blood Donor Collection, and nasal curettes for rapid viral testing.

The MRSA testing market report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:

• 3M Co.
• Abbott Laboratories
• ALIFAX Srl
• Becton Dickinson and Co.
• bioMerieux SA
• Bio Rad Laboratories Inc.
• Bruker Corp.
• Creative Diagnostics
• Danaher Corp.
• DiaSorin Spa
• Eurofins Scientific SE
• F. Hoffmann La Roche Ltd.
• GENSPEED Biotech GmbH
• OpGen Inc.
• Puritan Medical Products Co.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Market Segmentation

The market share growth by the hospital and diagnostic laboratories segment will be significant during the market forecasting period. Hospitals and diagnostic laboratories are an integral part of disease diagnosis, treatment, monitoring response to treatment, disease surveillance programs, and clinical research. Diagnostic techniques enable prompt and early intervention, thereby reducing disease burden and promoting health. The data obtained from patient samples are used for determining the medication required for MRSA.

Get a glance at the market contribution of various segments Request Market Research Report Sample PDF

The hospital and diagnostic laboratories segment was valued at USD 412 million in 2018. Hospital-based reference laboratories collaborate only with hospitals for MRSA testing. Hospitals refer only a few complicated tests to these laboratories because of the large volume of patients in hospitals, long turnaround times, and high costs. These laboratories manage the high-test volume with advanced instruments and trained laboratory technicians. Similarly, Clinical-based reference laboratories are privately held reference laboratories that offer diagnostic and testing services for clinics. These reference laboratories are small and usually get references from small clinics, offices of healthcare professionals, and nursing homes. They do not have advanced and expensive equipment for rare and critical diagnoses, and hence they outsource the tests or diagnostics process to reference laboratories. Moreover, In some regions like China, India, and Brazil, the number of small clinics is increasing to meet the growing patient demand, which is expected to drive the growth of the methicillin-resistant staphylococcus aureus testing market in focus during the forecast period.

Key Region

For more insights on the market share of various regions Request Market Research Report Sample PDF

North America is estimated to contribute 42% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. The methicillin-resistant staphylococcus aureus testing market in North America is witnessing significant growth, primarily because of the increasing demand for diagnostics such as HA-MRSA and CA-MRSA across different countries in North America. This has been brought about by the increased awareness among people to get diagnosed with MRSA infections. Most individuals in developed countries like US and Canada are opting for these tests, which has increased the sales of MRSA testing products in the market.

The outbreak of COVID-19 resulted in the shutdown of several manufacturing facilities in the US.  However, the COVID-19 outbreak had a positive impact on the growth of the regional MRSA testing market during 2024-2028, owing to the increased need for hygiene control for people with COVID-19 in 2020. The outbreak prompted companies of MRSA testing to increase production to meet the growing demand. This is coupled with the fact that North America is one of the fastest-growing regions in the market in focus. The regional market is expected to witness a growth rate of 11.29% in 2023 and 11.49% in 2024. Such factors are anticipated to propel the growth of the regional market during the forecast period. 

Segment Overview

The market research report provides comprehensive data (region wise segment analysis), with forecasts and estimates in "USD Million" for the period 2024 to 2028, as well as historical data from 2018 to 2022 for the following segments

• End-user Outlook
  • Hospitals and diagnostic laboratories
  • Academic and research institutes

• Type Outlook
  • Molecular diagnostics
  • Immunodiagnostics

• Region Outlook
  • North America
    • The U.S.
    • Canada
  • Europe
    • The U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia
    • China
    • India
  • ROW
    • Argentina
    • Austalia
    • Rest of the world

You may also be interested in:

• Microfluidic Market for Healthcare Applications Market Analysis North America, Europe, APAC, South America, Middle East and Africa - US, China, Japan, Germany, UK - Size and Forecast
• Hospital Infection Therapeutics Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, China, France, UK - Size and Forecast
• Antibiotics Market Analysis Asia, North America, Europe, Rest of World (ROW) - US, China, India, UK, Japan - Size and Forecast

Market Analyst Overview

MRSA testing is a crucial process in the electronics industry to ensure the quality and reliability of Surface Mount Technology (SMT) applications in various sectors. The market for MRSA testing is witnessing significant growth due to the increasing demand for Electronic Devices (EDs), PCBs (Printed Circuit Boards), and components such as Active and Passive Components. The integration of Automation, Robotics, Artificial Intelligence (AI), and Machine Learning (ML) in manufacturing processes has led to an increased focus on MRSA testing for improved efficiency and accuracy. Inspection Equipment and Soldering Equipment are essential tools for MRSA testing, ensuring the proper placement and connection of components on PCBs. Cleaning Equipment is also vital to maintain the cleanliness of the manufacturing environment and prevent contamination. Designing Services, Supply Chain Services, Manufacturing Services, and Aftermarket Services are other key areas where MRSA testing plays a significant role. The market for MRSA testing is expanding in various industries, including Consumer Electronics, IT & Telecommunication, Industrial, Aerospace & Defense, and Healthcare. New product launches, defense spending, and the adoption of advanced technologies like Silicon Carbide (SiC) in Electric Vehicles (EVs) and Solar panels are driving the growth of the MRSA testing market. For instance, Micron Technology, a leading semiconductor company, has recently launched new memory solutions that require stringent MRSA testing to ensure their reliability and performance. The IPC, a global industry association for printed board manufacturing, also emphasizes the importance of MRSA testing in its standards and guidelines.

The global MRSA testing market is witnessing significant growth due to the rising incidence of staphylococcus aureus bloodstream infections caused by methicillin-resistant strains. MRSA, a type of multi-drug resistant bacteria, is a public health threat that can lead to various types of infections, including surgical sites, skin diseases, and chronic diseases. To combat MRSA infections, various reagents and kits, such as immunodiagnostic tests and molecular diagnostic tests, are being used for clinical assessment and laboratory tests. Hospitals, hospital pharmacies, retail pharmacies, and online pharmacies are major consumers of these testing kits in the pharmaceutical and healthcare industry. MRSA therapy includes next-generation antibiotics like vancomycin and daptomycin, which belong to glycopeptides, lipopeptides, and oxazolidinones. Other drug classes used for MRSA therapy include beta-lactam antibiotics, cephalosporins, tetracyclines, lipoglycopeptides, folate antagonists, fluoroquinolones, and streptogramins.

Vancomycin, a widely used antibiotic for MRSA therapy, is available in oral and parenteral forms. Other therapeutic solutions include Zevtera, a cephalosporin antibiotic, and antiseptics for skin disease treatment. The growing prevalence of antibiotic-resistant strains of MRSA necessitates the development of alternative antibiotics and diagnostic tests to combat this global health concern. In conclusion, the MRSA testing market is expected to grow significantly due to the increasing incidence of MRSA infections and the need for accurate diagnostic tests and effective therapeutic solutions. The market is driven by the pharmaceutical and healthcare industry, hospital-acquired MRSA infections, and the development of next-generation antibiotics like glycopeptides, lipopeptides, and oxazolidinones.

Request Market Research Report Sample PDF

What are the Key Data Covered in this MRSA Testing Market Research Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the growth of the MRSA testing market between 2023 and 2027
• Precise estimation of the size of the MRSA testing market size and its contribution to the parent market
• Accurate predictions about upcoming trends and changes in consumer behavior
• Growth of the market industry across North America, Europe, Asia, and Rest of World (ROW)
• Thorough analysis of the market’s competitive landscape and detailed information about companies
• Comprehensive analysis of factors that will challenge the growth of MRSA testing market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch